The Organisation of Pharmaceutical Producers of India (OPPI) organised its flagship Annual Summit recently in New Delhi. The summit brought together a distinguished assembly of key government officials, regulators, industry leaders, member organisations, academia, patient support groups, innovators and other key stakeholders.
Centered around the theme Viksit Bharat @2047 –India’s Path from the "Pharmacy of the World" to the “Pharma Powerhouse to the World”, the summit set forth the vision for India's healthcare evolution. The platform witnessed deliberations on pivotal topics including innovation, skills development and technology, with a strong focus on advancing accessible and high-quality healthcare services across the nation.
The summit also witnessed the launch of reports and informative booklets, “Viksit Bharat@2047 - Transforming India from Pharmacy of the World to Pharma Powerhouse to the World" in collaboration with EY and "Winning in Indian Healthcare", in collaboration with BCG. Additionally, informative booklets on “Over the Counter (OTC) Drugs” and the “Value of Innovation” were released, highlighting the significance of innovation and creating awareness on OTC drugs.
The EY-OPPI report, titled Viksit Bharat@2047 - Transforming India from Pharmacy of the World to Pharma Powerhouse to the World, highlights the key growth imperatives required for India’s pharmaceutical sector to become a global powerhouse. It envisions a resilient, inclusive healthcare ecosystem where policymakers, providers, pharma companies and patient advocates collaborate to elevate patient care. Achieving these goals will position India’s healthcare model as a beacon of innovation and equitable access for the world.
As India’s pharmaceutical market gears for transformative growth, the "Winning in Indian Healthcare" report by BCG and OPPI explores the dynamic forces reshaping this critical sector. Against the backdrop of rapid economic growth, streamlined government policies, and digital health innovations, the report unpacks India’s unique healthcare potential. It highlights the drivers for growth (rising demand driven by an aging population, a burgeoning middle class, and a chronic disease burden), alongside challenges such as regulatory complexities, fragmented payer coverage, and market complexities. To thrive in this evolving landscape, global pharma players must rethink the portfolio strategy, invest in access initiatives, and embrace wider ecosystem partnerships. This report serves as a strategic guide for navigating India’s vibrant but challenging healthcare ecosystem.
The exceptional contributors and innovators in the healthcare sector were celebrated and recognised with the prestigious OPPI Awards. These awards honoured excellence, innovation, and a steadfast commitment to enhancing healthcare in Bharat. The esteemed awardees for 2024 included:
|
OPPI Lifetime Achievement Award 2024 |
Dr Gullapalli N. Rao, Founder Chair, L V Prasad Eye Institute |
|
OPPI Scientist Award 2024 |
|
|
Scientist of the Year |
Dr Arun Kumar Shukla, Professor and Sonu Agrawal Memorial Chair, Indian Institute of Technology, Kanpur |
|
Woman Scientist of the Year |
Prajakta Dandekar Jain, Co-ordinator, M.Tech. Pharmaceutical Biotechnology Program, UGC Assistant Professor in Engineering Sciences, Institute of Chemical Technology, Mumbai |
|
Young Scientist of the Year |
Rachit Agarwal, Associate Professor, Indian Institute of Science |
|
OPPI Excellence in Innovation Healthcare Start-up of the Year 2024 |
Neodocs |
